Alliance Pharma (APH)

 36.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 38.50
  • 52 Week Low: 23.00
  • Currency: UK Pounds
  • Shares Issued: 248.57m
  • Volume: 48,845
  • Market Cap: £91.35m
  • RiskGrade: 83
  • Beta: 0.03

Regulatory News

Exercise of Share Options 14-Jan-2013 14:13 RNS
CULS Conversion and Additional Listing 10-Jan-2013 16:23 RNS
CULS Conversion and Additional Listing 10-Dec-2012 11:33 RNS
Exercise of Options 07-Dec-2012 09:42 RNS
Amended Notice - Exercise of Share Options 03-Dec-2012 12:09 RNS
Exercise of Share Options 29-Nov-2012 16:13 RNS
CULS Conversion 12-Nov-2012 17:15 RNS
TR-1: Notification of Major Interest in Shares 30-Oct-2012 16:25 RNS
Director Sahreholding 30-Oct-2012 15:26 RNS
Director's Dealings 26-Oct-2012 11:30 RNS
Share Options 19-Oct-2012 16:37 RNS
Exercise of Share Options 19-Oct-2012 16:04 RNS
Acquisition 19-Oct-2012 07:00 RNS
Interim Results 12-Sep-2012 07:00 RNS
Notice of Interim Results 10-Aug-2012 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 36.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 38.50
52 Week Low 23.00
Volume 48,845
Shares Issued 248.57m
Market Cap £91.35m
Beta 0.03
RiskGrade 83

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.53% above the market average29.53% above the market average29.53% above the market average29.53% above the market average29.53% above the market average
86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average
Price Trend
30.90% above the market average30.90% above the market average30.90% above the market average30.90% above the market average30.90% above the market average
28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average
Income
23.18% above the market average23.18% above the market average23.18% above the market average23.18% above the market average23.18% above the market average
63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average63.64% above the sector average
Growth
54.25% below the market average54.25% below the market average54.25% below the market average54.25% below the market average54.25% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 4
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 12-Jun-13 05-Dec-12
Paid 11-Jul-13 15-Jan-13
Amount 0.55p 0.28p

Trades for 21-May-2013

Time Volume / Share Price
16:22 1,350 @ 37.00p
13:35 10,650 @ 36.95p
12:48 1,286 @ 36.86p
12:17 5,275 @ 36.95p
12:13 1,335 @ 36.95p

Alliance Pharma Key Personnel

CEO John Dawson
Finance Director Richard Wright

Top of Page